IL20 and breast cancer: As previously reported, IL-20 was highly expressed in BC tissue and enhanced breast tumor growth in in vitro and in vivo models, triggering the activation of both signaling pathways involved in cellular proliferation (see Section 4.1.2) and antiapoptotic-associated signals such as Bcl-XL and Bad.